A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer



Status:Recruiting
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/3/2019
Start Date:December 2015
End Date:July 2021
Contact:Seattle Genetics Trial Information Support
Email:clinicaltrials@seagen.com
Phone:866-333-7436

Use our guide to learn which trials are right for you!

Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs Placebo in Combination With Capecitabine and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma

This study is being done to see if tucatinib works better than placebo to help patients who
have a specific type of breast cancer called HER2 positive breast carcinoma. The breast
cancer in this study is either metastatic (spread into other parts of the body) or cannot be
removed completely with surgery. All patients in the study will get capecitabine and
trastuzumab, two drugs that are often used to treat this cancer.

Patients in this study will be randomly assigned to get either tucatinib or placebo (a pill
with no medicine). This is a blinded study, so neither patients nor their doctors will know
whether a patient gets tucatinib or placebo.

Each treatment cycle lasts 21 days. Patients will swallow tucatinib pills or placebo pills
two times every day. They will swallow capecitabine pills two times a day during the first
two weeks of each cycle. Patients will get trastuzumab injections from the study site staff
on the first day of every cycle.

This is a randomized, international, multi-center, double-blinded study in patients with
progressive unresectable locally advanced or metastatic HER2+ breast cancer who have had
prior treatment with trastuzumab, pertuzumab and T-DM1. Patients will be randomized in a 2:1
ratio to receive tucatinib or placebo in combination with capecitabine and trastuzumab.

Stratification factors include presence or history of treated or untreated brain metastases
or brain lesions of equivocal significance (yes/no), Eastern Cooperative Oncology Group
(ECOG) Performance Status (0 vs. 1), and region of world (US vs. Canada vs. Rest of World).

No crossover from placebo to tucatinib will be allowed.

Safety assessments will be performed at a minimum of once every three weeks throughout study
treatment and 30 days after the last dose of study drugs. Laboratory assessments will be
performed locally at sites. Left ventricular ejection fraction will be assessed by MUGA or
ECHO at screening and once every 12 weeks thereafter.

Contrast brain MRI will be performed at baseline in all patients. Efficacy assessments (CT of
chest, abdomen and pelvis at a minimum) utilize RECIST 1.1 and include patients with
evaluable tumors defined as measurable target lesions and non-measurable non-target lesions.
RECIST assessment is performed at baseline, every 6 weeks for the first 24 weeks, and then
every 9 weeks thereafter. Repeat MRI of the brain will be required on this same schedule only
in those patients with brain metastases identified at baseline. All treatment decisions are
made based upon investigator assessment. All patients undergo a repeat MRI of the brain
within 30 days of the end of treatment unless previously performed at time of disease
progression. Patients in both arms of the study will be followed for OS after completion of
study treatment.

Inclusion Criteria

- Histologically confirmed HER2+ breast carcinoma, with HER2+ defined by in situ
hybridization (ISH) or fluorescence in situ hybridization (FISH) methodology

- Received previous treatment with trastuzumab, pertuzumab, and T-DM1

- Progression of unresectable locally advanced or metastatic breast cancer after last
systemic therapy (as confirmed by investigator), or be intolerant of last systemic
therapy

- Have measurable or non-measurable disease assessable by RECIST 1.1

- Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1

- Adequate hepatic and renal function

- Left ventricular ejection fraction (LVEF) ≥ 50%

- CNS Inclusion - Based on screening brain magnetic resonance imaging (MRI), patients
must have one of the following:

1. No evidence of brain metastases

2. Untreated brain metastases not needing immediate local therapy

3. Previously treated brain metastases not needing immediate local therapy

1. Brain metastases previously treated with local therapy may either be stable
since treatment or may have progressed since prior local CNS therapy

2. Patients treated with CNS local therapy for newly identified lesions found
on contrast brain MRI performed during screening for this study may be
eligible to enroll if the following criteria are met:

- Time since whole brain radiation therapy (WBRT) is ≥ 21 days prior to
first dose of study treatment, time since stereotactic radiosurgery
(SRS) is ≥ 7 days prior to first dose of study treatment, or time since
surgical resection is ≥ 28 days.

- Other sites of disease assessable by RECIST 1.1 are present

3. Relevant records of any CNS treatment must be available to allow for
classification of target and non-target lesions

Exclusion Criteria

- Previously been treated with:

1. lapatinib within 12 months of starting study treatment (except in cases where
lapatinib was given for ≤ 21 days and was discontinued for reasons other than
disease progression or toxicity)

2. neratinib, afatinib, or other investigational HER2/epidermal growth factor
receptor (EGFR) tyrosine kinase inhibitor (TKI) at any time previously

3. capecitabine (or other fluoropyrimidine) for metastatic disease except in cases
where capecitabine was given for < 21 days and was discontinued for reasons other
than disease progression or toxicity. Patients who have received capecitabine for
adjuvant or neoadjuvant treatment at least 12 months prior to starting study
treatment are eligible.

- Clinically significant cardiopulmonary disease

- Carriers of Hepatitis B or Hepatitis C or have other known chronic liver disease

- Positive for human immunodeficiency virus (HIV)

- Unable for any reason to undergo MRI of the brain

- Have used a strong CYP3A4 or CYP2C8 inhibitor within 5 half-lives of the inhibitor, or
a strong CYP3A4 or CYP2C8 inducer within 5 days prior to first dose of study treatment

- CNS Exclusion - Based on screening brain MRI, patients must not have any of the
following:

1. Any untreated brain lesions > 2.0 cm in size, unless approved by medical monitor

2. Ongoing use of systemic corticosteroids for control of symptoms of brain
metastases at a total daily dose of > 2 mg of dexamethasone (or equivalent)

3. Any brain lesion thought to require immediate local therapy. Patients who undergo
local treatment for such lesions identified by screening contrast brain MRI may
still be eligible for the study based on criteria described under CNS inclusion
criteria

4. Known or suspected leptomeningeal disease (LMD)

5. Poorly controlled seizures
We found this trial at
82
sites
Atlanta, Georgia 30322
Principal Investigator: Elisavet Paplomata
Phone: 404-778-1900
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
Principal Investigator: Erica Stringer-Reasor
Phone: 205-934-7167
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
3550 Jerome Avenue
Bronx, New York 10467
(718) 920-4321
Principal Investigator: Sun Oh
Phone: 718-920-4826
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
?
mi
from
Bronx, NY
Click here to add this to my saved trials
5801 South Ellis Avenue
Chicago, Illinois 60637
 773.702.1234
Principal Investigator: Olwen Hahn
Phone: 773-834-9774
University of Chicago One of the world's premier academic and research institutions, the University of...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Miami, Florida 33124
(305) 284-2211
Principal Investigator: Frances Valdes-Albini
Phone: 954-210-1171
University of Miami A private research university with more than 15,000 students from around the...
?
mi
from
Miami, FL
Click here to add this to my saved trials
1211 Medical Center Dr
Nashville, Tennessee 37232
(615) 322-5000
Principal Investigator: Vandana Abramson
Phone: 615-875-9636
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
?
mi
from
Nashville, TN
Click here to add this to my saved trials
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
503 494-8311
Principal Investigator: Kathleen Kemmer
Phone: 503-494-0543
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
?
mi
from
Portland, OR
Click here to add this to my saved trials
4805 Northeast Glisan Street
Portland, Oregon 97213
(503) 215-1111
Principal Investigator: Alison Conlin
Phone: 503-215-2619
Providence Portland Medical Center We strive to give those we serve exceptional, compassionate health care...
?
mi
from
Portland, OR
Click here to add this to my saved trials
201 Presidents Circle
Salt Lake City, Utah 84108
801) 581-7200
Principal Investigator: Adam Cohen
Phone: 801-585-0303
University of Utah Research is a major component in the life of the U benefiting...
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
4502 Medical Drive
San Antonio, Texas 78284
(210) 567-7000
Principal Investigator: Andrew Brenner
Phone: 210-450-5962
University of Texas Health Science Center at San Antonio The University of Texas Health Science...
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
12902 USF Magnolia Dr
Tampa, Florida 33612
(888) 663-3488
Principal Investigator: Hatem Soliman
Phone: 813-745-3007
H. Lee Moffitt Cancer Center & Research Institute Moffitt Cancer Center in Tampa, Florida, has...
?
mi
from
Tampa, FL
Click here to add this to my saved trials
1000 Johnson Ferry Rd NE
Atlanta, Georgia 30342
(404) 851-8000
Principal Investigator: Amelia Zelnak
Phone: 770-496-9457
Northside Hospital Northside Hospital-Atlanta (in Sandy Springs) opened in 1970. The original facility had 250...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Augusta, Georgia 30912
Principal Investigator: Allan Krutchik
Phone: 706-446-5177
?
mi
from
Augusta, GA
Click here to add this to my saved trials
Aurora, Colorado 80045
Principal Investigator: Virginia Borges
Phone: 720-848-9456
?
mi
from
Aurora, CO
Click here to add this to my saved trials
Austin, Texas 78705
Principal Investigator: XXUyeki
Phone: 512-427-9400
?
mi
from
Austin, TX
Click here to add this to my saved trials
Baltimore, Maryland 20742
(301) 405-1000
Principal Investigator: Katherine H. R. Tkaczuk
Phone: 410-328-3546
University of Maryland As a globally-connected university offering a world-class education, the University of Maryland...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
450 Brookline Ave
Boston, Massachusetts 2215
617-632-3000
Principal Investigator: Nancy Lin
Phone: 617-632-3000
Dana-Farber Cancer Institute Since it’s founding in 1947, Dana-Farber has been committed to providing adults...
?
mi
from
Boston, MA
Click here to add this to my saved trials
Chapel Hill, North Carolina 27599
Principal Investigator: Lisa Carey
Phone: 984-974-8249
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Charleston, South Carolina 29401
Principal Investigator: Steven Akman
Phone: 843-958-2666
?
mi
from
Charleston, SC
Click here to add this to my saved trials
Charleston, South Carolina 29425
Principal Investigator: Sara Giordano
Phone: 843-792-5853
?
mi
from
Charleston, SC
Click here to add this to my saved trials
1653 W. Congress Parkway
Chicago, Illinois 60612
(312) 942-5000
Principal Investigator: Melody Cobleigh
Phone: 312-563-4101
Rush University Medical Center Rush University Medical Center encompasses a 664-bed hospital serving adults and...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Columbus, Ohio 43210
Principal Investigator: Maryam Lustberg
Phone: 614-293-5655
?
mi
from
Columbus, OH
Click here to add this to my saved trials
1441 North Beckley Avenue
Dallas, Texas 75203
Principal Investigator: Inna Shmerlin
Phone: 281-863-6460
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Denton, Texas 76210
Principal Investigator: Sharad Jain
Phone: 940-382-1022
?
mi
from
Denton, TX
Click here to add this to my saved trials
Detroit, Michigan 48202
Principal Investigator: Thomas Doyle
Phone: 313-916-2631
?
mi
from
Detroit, MI
Click here to add this to my saved trials
1500 East Duarte Road
Duarte, California 91010
626-256-HOPE (4673)
Principal Investigator: Mina Sedrak
Phone: 626-256-4673
City of Hope National Medical Center City of Hope is dedicated to making a difference...
?
mi
from
Duarte, CA
Click here to add this to my saved trials
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Principal Investigator: Kelly Westbrook
Phone: 919-660-1278
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
?
mi
from
Durham, NC
Click here to add this to my saved trials
8503 Arlington Blvd., Ste. 400
Fairfax, Virginia 22031
(703) 280-5390
Principal Investigator: Patricia Rodriguez
Phone: 703-280-5139
Virginia Cancer Specialists, PC Now the world's most advanced cancer treatment capabilities can be found...
?
mi
from
Fairfax, VA
Click here to add this to my saved trials
3840 Broadway
Fort Myers, Florida 33901
Principal Investigator: Lowell Hart
Phone: 239-274-9930
?
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Fort Worth, Texas 76104
Principal Investigator: Robyn Young
Phone: 817-759-7020
?
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Goodyear, Arizona 85338
Principal Investigator: Cynthia Lynch
Phone: 623-207-3126
?
mi
from
Goodyear, AZ
Click here to add this to my saved trials
Greenville, North Carolina 27834
Principal Investigator: Mahvish Muzaffar
Phone: 252-744-5723
?
mi
from
Greenville, NC
Click here to add this to my saved trials
30 Prospect Ave
Hackensack, New Jersey 07601
(201) 996-2000
Principal Investigator: Deena Graham
Phone: 551-996-8258
Hackensack University Medical Center Hackensack University Medical Center, part of the Hackensack University Health Network,...
?
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Heidelberg,
Principal Investigator: Belinda Yeo
Phone: 866-333-7436
?
mi
from
Heidelberg,
Click here to add this to my saved trials
Hollywood, Florida 33021
Principal Investigator: Aurelio Castrellon
Phone: 954-265-2615
?
mi
from
Hollywood, FL
Click here to add this to my saved trials
Houston, Texas 77024
Principal Investigator: Michelina XxCairo
Phone: 713-467-1722
?
mi
from
Houston, TX
Click here to add this to my saved trials
Houston, Texas 77030
Principal Investigator: Rashmi Murthy
Phone: 713-745-6263
?
mi
from
Houston, TX
Click here to add this to my saved trials
Houston, Texas 77005
Principal Investigator: Mothaffar Rimawi
Phone: 713-798-7315
?
mi
from
Houston, TX
Click here to add this to my saved trials
Jacksonville, Florida 32207
Principal Investigator: Jennifer Crozier
Phone: 844-632-2278
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
4321 Washington Street #4000
Kansas City, Missouri 64111
(816) 932-3300
Principal Investigator: Timothy Pluard
Phone: 816-932-2562
Saint Luke's Cancer Institute Hope is an important part of the arsenal that helps patients...
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
Kingsport, Tennessee 37660
Principal Investigator: Asheesh Shipstone
Phone: 423-578-8538
?
mi
from
Kingsport, TN
Click here to add this to my saved trials
Lebanon, New Hampshire 03756
Principal Investigator: Gary Schwartz
Phone: 603-650-5000
?
mi
from
Lebanon, NH
Click here to add this to my saved trials
Los Angeles, California 90095
Principal Investigator: Placeholder TRIO
Phone: 000-000-0000
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
757 Westwood Plaza
Los Angeles, California 90095
Principal Investigator: Sara Hurvitz
Phone: 310-582-6324
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Lubbock, Texas 79410
Principal Investigator: Ibrahim Shalaby
Phone: 806-725-8065
?
mi
from
Lubbock, TX
Click here to add this to my saved trials
Madison, Wisconsin
Principal Investigator: Ruth O'Regan
Phone: 608-265-2857
?
mi
from
Madison, WI
Click here to add this to my saved trials
Miami Beach, Florida 33140
Principal Investigator: Elisa Krill-Jackson
Phone: 305-674-2625
?
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Minneapolis, Minnesota 55408
Principal Investigator: Michaela Tsai
Phone: 612-863-1093
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
1660 Springhill Avenue
Mobile, Alabama 36604
(251) 665-8000
Principal Investigator: Teja Poosarla
Phone: 251-445-9870
University of South Alabama Mitchell Cancer Institute USA Mitchell Cancer Institute (MCI) is located in...
?
mi
from
Mobile, AL
Click here to add this to my saved trials
Nashville, Tennessee 37203
Principal Investigator: Erika Hamilton
Phone: 615-329-7274
?
mi
from
Nashville, TN
Click here to add this to my saved trials
333 Cedar Street
New Haven, Connecticut 06520
(203) 785-4095
Principal Investigator: Michael DiGiovanna
Phone: 203-737-3472
Yale Cancer Center Yale Cancer Center combines a tradition of innovative cancer treatment and quality...
?
mi
from
New Haven, CT
Click here to add this to my saved trials
New York, New York 10003
Principal Investigator: Stephen Malamud
Phone: 212-367-0126
?
mi
from
New York, NY
Click here to add this to my saved trials
New York, New York 10016
Principal Investigator: Nina D'Abreo
Phone: 516-663-1237
?
mi
from
New York, NY
Click here to add this to my saved trials
Newnan, Georgia 30265
Principal Investigator: Ricardo Alvarez
Phone: 770-400-6273
?
mi
from
Newnan, GA
Click here to add this to my saved trials
Niles, Illinois 60714
Principal Investigator: Susan Brown
Phone: 847-827-9060
?
mi
from
Niles, IL
Click here to add this to my saved trials
Omaha, Nebraska 68114
Principal Investigator: Margaret Block
Phone: 402-691-6972
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Orlando, Florida 32806
Principal Investigator: Rebecca Moroose
Phone: 321-841-4348
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Paris, Texas 75460
Principal Investigator: Sucharu Prakash
Phone: 903-785-0031
?
mi
from
Paris, TX
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
Principal Investigator: Amy Clark
Phone: 215-615-4822
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19124
Principal Investigator: Sramila Aithal
Phone: 215-537-4881
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phoenix, Arizona 85016
Principal Investigator: Govardhanan Nagaiah
Phone: 602-274-5141
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Plano, Texas 75075
Principal Investigator: Christopher Stokoe
Phone: 972-867-3577
?
mi
from
Plano, TX
Click here to add this to my saved trials
Redondo Beach, California 90277
Principal Investigator: David Chan
Phone: 310-750-3377
?
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Rockville, Maryland 20850
Principal Investigator: Cheryl Aylesworth
Phone: 301-933-3216
?
mi
from
Rockville, MD
Click here to add this to my saved trials
Royal Oak, Michigan 48073
Principal Investigator: Padmaja Venuturumilli
Phone: 248-551-8429
?
mi
from
Royal Oak, MI
Click here to add this to my saved trials
1201 5th Avenue North
Saint Petersburg, Florida 33705
Principal Investigator: Gail Wright
Phone: 727-216-1143
?
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
San Antonio, Texas 78212
Principal Investigator: Sharon Wilks
Phone: 210-424-2631
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
San Francisco, California 94143
Principal Investigator: Jo Chien
Phone: 415-353-3003
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
San Marcos, California 92078
Principal Investigator: Jonathan Polikoff
Phone: 949-455-8552
?
mi
from
San Marcos, CA
Click here to add this to my saved trials
Santa Maria, California 93454
Principal Investigator: Robert Dichmann
Phone: 805-346-3462
?
mi
from
Santa Maria, CA
Click here to add this to my saved trials
Seattle, Washington 98104
Principal Investigator: Tanya Wahl
Phone: 206-386-2828
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Seattle, Washington 98109
Principal Investigator: Jennifer Specht
Phone: 206-606-1171
?
mi
from
Seattle, WA
Click here to add this to my saved trials
3 Edmund D. Pellegrino Road
Stony Brook, New York 11794
(631) 638-1000
Principal Investigator: Alison Stopeck
Phone: 631-638-0815
Stony Brook University Cancer Center Ask a cancer survivor. Having highly advanced care close to...
?
mi
from
Stony Brook, NY
Click here to add this to my saved trials
The Woodlands, Texas 77380
Principal Investigator: Sharon Wilks
Phone: 281-863-5665
?
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Tualatin, Oregon 97062
Principal Investigator: David Cosgrove
Phone: 360-449-6522
?
mi
from
Tualatin, OR
Click here to add this to my saved trials
602 W University Ave
Urbana, Illinois 61801
(217) 383-3010
Principal Investigator: Kendrith Rowland
Phone: 217-383-6828
Carle Cancer Center Carle Cancer Center delivers comprehensive care through leading-edge technology and advanced research,...
?
mi
from
Urbana, IL
Click here to add this to my saved trials
Vallejo, California 94589
Principal Investigator: Jennifer Suga
Phone: 707-651-2797
?
mi
from
Vallejo, CA
Click here to add this to my saved trials
Washington, District of Columbia 20007
Principal Investigator: Paula Pohlmann
Phone: 202-444-2209
?
mi
from
Washington,
Click here to add this to my saved trials
Webster, Texas 77598
Principal Investigator: Dhatri Kodali
Phone: 281-332-7505
?
mi
from
Webster, TX
Click here to add this to my saved trials
West Palm Beach, Florida 33401
Principal Investigator: Marilyn Raymond
Phone: 561-366-4100
?
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Westwood, Kansas 66205
Principal Investigator: Qamar Khan
Phone: 913-588-6029
?
mi
from
Westwood, KS
Click here to add this to my saved trials
Winchester, Virginia 22601
Principal Investigator: William Houck III
Phone: 540-662-1108
?
mi
from
Winchester, VA
Click here to add this to my saved trials